Zobrazeno 71 - 80
of 236
pro vyhledávání: '"Sarah L. Mott"'
Autor:
Bradley T. Loeffler, Bradley A. Erickson, Sarah L. Mott, Hannah E. Botkin, Kathryn N. Faidley, Emily K. Hill
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:The proximity of the cervix to the trigone makes hydronephrosis (HN) a common comorbid condition with cervical cancer (CCa). Treatments for CCa continue to improve and ac...
Autor:
Margaret E, Long, Andrew M, Vitale, Sarah L, Mott, Chad, Tracy, Rohan, Garje, Yousef, Zakharia, James A, Brown
Publikováno v:
The Canadian journal of urology. 28(4)
INTRODUCTION Androgen deprivation therapy (ADT) is often used in the treatment of prostate cancer. Specific factors affecting testosterone recovery after cessation of ADT have not been well-characterized in existing literature.We retrospectively revi
Autor:
Kimberly A Dukes, Autumn C Bahlmann, Muhammad Furqan, Sarah L. Mott, Douglas E Laux, Zachary J Pollock, Aaron T Seaman, David A. Katz, Mark W. Vander Weg, Jane A Utech
Publikováno v:
Transl Behav Med
Few cancer patients receive guideline-concordant care for treatment of tobacco dependence. The purpose of this pilot trial was to obtain preliminary estimates of effectiveness of an evidence-based practice intervention on the delivery of tobacco trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339f0e1776607e75ac7df844ff2a7f41
https://europepmc.org/articles/PMC8529899/
https://europepmc.org/articles/PMC8529899/
Autor:
Bradley A. Erickson, Emily K. Hill, Kathryn N. Faidley, Sarah L. Mott, Hannah E. Botkin, Bradley T. Loeffler
Publikováno v:
Urology. 158
To identify predictors of hydronephrosis (HN) resolution and HN treatment failure. HN is a common comorbid condition with cervical cancer (CCa). Treatments for CCa continue to improve and long-term management strategies of HN are becoming increasingl
Autor:
Kokou D. Zamba, Maheen Rajput, David P. Kuehn, Jon Houtman, Chinemerem Abanonu, Steven Varga, Laura Stephens, Varun Monga, Sarah L. Mott, Weizhou Zhang, Lei Wang, Munir R. Tanas, Omar Jaber, Sudershan K. Bhatia, Catherine M. Metz, Sarag Boukhar, Bryan G. Allen, Jon Thomason, Benjamin J. Miller, Carryn M. Anderson, Stacey Hartwig, Mohammed M. Milhem
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundSoft-tissue sarcomas (STS) in the extremities and trunk treated with standard-of-care preoperative external beam radiation therapy (EBRT) followed by surgical resection are associated with local and distant relapses. In preclinical studies,
Publikováno v:
Prostate Cancer Prostatic Dis
BACKGROUND: Expectant management (EM) has been widely recommended for men with low-risk prostate cancers (PCa). We evaluated trends in EM and the sociodemographic and clinical factors associated with EM, initiating a National Comprehensive Cancer Net
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a4f3a97ca1babfd102a64aef8cae75
https://europepmc.org/articles/PMC8976291/
https://europepmc.org/articles/PMC8976291/
Autor:
Shaikamjad Umesalma, Chandra K. Maharjan, Kokou D. Zamba, Sarah L. Mott, Samuel B. Stephens, Courtney A. Kaemmer, Mariah R. Leidinger, David K. Meyerholz, Patrick Breheny, Viviane P. Muniz, Casey J. Bauchle, Dawn E. Quelle, Benjamin W. Darbro
Publikováno v:
Biomedicines
Volume 9
Issue 6
Biomedicines, Vol 9, Iss 633, p 633 (2021)
Volume 9
Issue 6
Biomedicines, Vol 9, Iss 633, p 633 (2021)
Pancreatic neuroendocrine tumors (pNETs) are difficult-to-treat neoplasms whose incidence is rising. Greater understanding of pNET pathogenesis is needed to identify new biomarkers and targets for improved therapy. RABL6A, a novel oncogenic GTPase, i
Autor:
Bergljot R. Karlsdottir, Peige P. Zhou, Joyce Wahba, Sarah L. Mott, Paolo Goffredo, Jennifer Hrabe, Imran Hassan, Muneera R. Kapadia, Irena Gribovskaja-Rupp
Publikováno v:
International Journal of Colorectal Disease. 37:1923-1923
Autor:
Cameron M. Callaghan, Ibrahim M. Abukhiran, Richard V. Van Rheeden, Amanda L. Kalen, Samuel N. Rodman, Michael S. Petronek, Kranti A. Mapuskar, Sarah L. Mott, Mitchell C. Coleman, Prabhat C. Goswami, John M. Buatti, Bryan G. Allen, Douglas R. Spitz, Joseph M. Caster
Publikováno v:
Cancer Research. 82:811-811
Purpose/Objective(s): The ATM protein is key to DNA double strand break (DSB) repair and ATM inhibitors are potent radiosensitizers. Clinical translation of these agents in combination with radiotherapy (RT) has been limited due to concerns for incre
Autor:
Josiah, An, Melissa, Yan, Nanmeng, Yu, Adithya, Chennamadhavuni, Muhammad, Furqan, Sarah L, Mott, Bradley T, Loeffler, Timothy, Kruser, Timothy L, Sita, Lawrence, Feldman, Ryan, Nguyen, Mary, Pasquinelli, Nasser H, Hanna, Taher, Abu Hejleh
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: STK11 mutation (STK11(m)) in patients (pts) with stage IV non-small cell lung cancer (NSCLC) is associated with inferior survival and poor response to immune checkpoint inhibitors (ICI). The significance of STK11(m) in stage III NSCLC pts